StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
20
Publishing Date
2023 - 12 - 18
1
2023 - 10 - 12
1
2023 - 09 - 12
1
2023 - 08 - 25
1
2023 - 07 - 26
1
2023 - 07 - 06
2
2023 - 06 - 26
1
2023 - 05 - 11
1
2023 - 04 - 27
1
2023 - 03 - 21
1
2023 - 03 - 17
1
2023 - 03 - 13
1
2023 - 02 - 06
1
2023 - 02 - 01
1
2022 - 12 - 08
1
2022 - 04 - 27
1
2022 - 04 - 13
1
2021 - 09 - 03
1
2021 - 06 - 07
1
Sector
Administrative and support and waste management and remediation services
4
Commercial services
40
Communications
36
Construction
1
Consumer durables
12
Consumer non-durables
15
Consumer services
21
Distribution services
14
Electronic technology
58
Energy minerals
29
Finance
198
Finance and insurance
13
Health care and social assistance
2
Health services
20
Health technology
1290
Industrial services
20
Information
10
Manufacturing
131
Mining, quarrying, and oil and gas extraction
24
Miscellaneous
1
N/a
123
Non-energy minerals
73
Process industries
53
Producer manufacturing
28
Professional, scientific, and technical services
20
Real estate and rental and leasing
1
Retail trade
9
Technology services
30
Transportation
19
Transportation and warehousing
3
Utilities
72
Wholesale trade
5
Tags
Acquisition
52
Agreement
52
Alzheimer’s
54
Application
60
Biopharma
91
Biotech-beach
52
Biotechnology
58
Business
115
Cancer
141
Ceo
47
Clinical-trials-phase-ii
48
Collaboration
49
Conference
417
Day
52
Disease
139
Drug
79
Earnings
81
Events
149
Fda
74
Financial
336
Financial results
102
Genetown
60
Genomics
45
Global
173
Group
41
Growth
150
Health
107
Management
57
Market
301
Meeting
112
Molecular
71
N/a
2940
Nasdaq
49
Offering
167
One
51
People
86
Pharm-country
60
Pharmaceuticals
111
Phase 2
55
Positive
94
Pre-clinical
44
Preclinical
86
Presentation
85
Program
64
Publication
56
Report
216
Research
209
Results
586
Rosa
42
Services
76
Software
51
Study
80
Technology
56
Test
47
Therapeutics
698
Therapy
77
Treatment
123
Trial
208
Update
183
Year
154
Entities
1847 holdings llc
3
Biorestorative therapies, inc.
1
Bioxytran, inc
2
Briacell therapeutics corp.
2
Dominari holdings inc
1
Endonovo therapeutics, inc.
1
Gain therapeutics inc
1
Greenlight biosciences inc
1
Healthcare integrated technologies inc.
1
Impel neuropharma inc.
1
Lianbio - adr
3
Panbela therapeutics inc
1
Synaptogenix inc
1
Transcode therapeutics inc
1
Symbols
BCTX
2
BIXT
2
BRTX
1
DOMH
1
EFSH
3
ENDV
1
GANX
1
GRNA
1
HITC
1
IMPL
1
LIAN
3
PBLA
1
RNAZ
1
SNPX
1
Exchanges
Nasdaq
20
Crawled Date
2023 - 12 - 18
1
2023 - 10 - 12
1
2023 - 09 - 12
1
2023 - 08 - 25
1
2023 - 07 - 26
1
2023 - 07 - 06
2
2023 - 06 - 26
1
2023 - 05 - 11
1
2023 - 04 - 27
1
2023 - 03 - 21
1
2023 - 03 - 17
1
2023 - 03 - 13
1
2023 - 02 - 06
1
2023 - 02 - 01
1
2022 - 12 - 08
1
2022 - 04 - 27
1
2022 - 04 - 13
1
2021 - 09 - 03
1
2021 - 06 - 07
1
Crawled Time
11:00
2
12:00
4
13:00
4
13:20
1
13:30
1
14:00
2
16:00
2
17:00
2
19:00
1
21:00
1
Source
spacfeed.com
2
www.biospace.com
5
www.globenewswire.com
11
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Professional, scientific, and technical services
tags :
Approval
save search
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Published:
2023-12-18
(Crawled : 13:00)
- globenewswire.com
PBLA
|
$0.525
-6.31%
38K
|
Professional, Scientific, and T...
|
-94.31%
|
O:
29.1%
H:
177.92%
C:
71.16%
approval
therapeutics
Endonovo's SofPulse® Secures Taiwan FDA Approval
Published:
2023-10-12
(Crawled : 13:00)
- globenewswire.com
ENDV
|
$0.0032
158.07%
280K
|
Professional, Scientific, and T...
|
-68.0%
|
O:
22.0%
H:
0.0%
C:
-11.48%
sofpulse
fda
approval
Gain Therapeutics Receives Approval to Commence Phase 1 Clinical Study of GT-02287 from the Human Research Ethics Committee (HREC) in Australia
Published:
2023-09-12
(Crawled : 13:30)
- globenewswire.com
GANX
|
$3.14
-0.63%
-0.64%
81K
|
Professional, Scientific, and T...
|
-13.11%
|
O:
4.37%
H:
2.98%
C:
-4.71%
gt-0228
australia
approval
research
therapeutics
study
BriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders
Published:
2023-08-25
(Crawled : 19:00)
- globenewswire.com
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
approval
therapeutics
LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA Approval of XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the Treatment of Demodex Blepharitis
Published:
2023-07-26
(Crawled : 12:00)
- globenewswire.com
LIAN
|
$4.92
0.41%
0.41%
410K
|
Professional, Scientific, and T...
|
144.5%
|
O:
5.0%
H:
4.29%
C:
-2.38%
fda
approval
treatment
pharmaceuticals
ACG Acquisition notes Brazil antitrust approval for mines acquisition – Morningstar
Published:
2023-07-06
(Crawled : 13:00)
- spacfeed.com
EFSH
4
|
$1.87
-19.74%
1.6%
230K
|
Professional, Scientific, and T...
|
-90.31%
|
O:
-0.62%
H:
0.0%
C:
-7.7%
approval
acquisition
brazil
ACG Acquisition notes Brazil antitrust approval for mines acquisition – Marketscreener.com
Published:
2023-07-06
(Crawled : 12:00)
- spacfeed.com
EFSH
4
|
$1.87
-19.74%
1.6%
230K
|
Professional, Scientific, and T...
|
-90.31%
|
O:
-0.62%
H:
0.0%
C:
-7.7%
approval
acquisition
brazil
LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singapore
Published:
2023-06-26
(Crawled : 12:00)
- globenewswire.com
LIAN
|
$4.92
0.41%
0.41%
410K
|
Professional, Scientific, and T...
|
102.9%
|
O:
1.66%
H:
1.91%
C:
-9.39%
camzyos
approval
LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in the Macau Special Administrative Region (SAR) of China
Published:
2023-05-11
(Crawled : 11:00)
- globenewswire.com
LIAN
|
$4.92
0.41%
0.41%
410K
|
Professional, Scientific, and T...
|
124.31%
|
O:
0.0%
H:
10.09%
C:
0.92%
camzyos
approval
china
TransCode Therapeutics Announces IRB Approval for FDA Cleared First-In-Human Clinical Trial
Published:
2023-04-27
(Crawled : 11:00)
- globenewswire.com
RNAZ
|
$0.5
-0.99%
-1.0%
280K
|
Professional, Scientific, and T...
|
-93.24%
|
O:
16.22%
H:
3.49%
C:
-22.26%
fda
cleared
approval
trial
therapeutics
Dominari Financial Granted Approval to Acquire Broker Dealer
Published:
2023-03-21
(Crawled : 21:00)
- prnewswire.com
DOMH
|
$2.88
3.6%
3.47%
3.1K
|
Professional, Scientific, and T...
|
-14.98%
|
O:
-1.53%
H:
4.35%
C:
-7.45%
granted
approval
acquire
financial
Healthcare Integrated Technologies, Inc. Announces Approval of U.S. Patent for Fall Validation with Privacy-Aware Monitoring System
Published:
2023-03-17
(Crawled : 14:00)
- globenewswire.com
HITC
|
$0.09
70.77%
17K
|
Professional, Scientific, and T...
|
-33.33%
|
O:
3.27%
H:
5.23%
C:
2.0%
patent
approval
system
BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100
Published:
2023-03-13
(Crawled : 12:00)
- biospace.com/
BRTX
|
$1.37
4.58%
4.38%
660K
|
Professional, Scientific, and T...
|
-56.62%
|
O:
-2.65%
H:
5.44%
C:
5.44%
brtx-100
fda
application
approval
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
Published:
2023-02-06
(Crawled : 16:00)
- biospace.com/
BIXT
|
$0.117
490.75%
140K
|
Professional, Scientific, and T...
|
-75.88%
|
O:
0.0%
H:
3.09%
C:
-2.06%
trials
approval
GreenLight Biosciences receives approval to initiate Phase I/II clinical trial of Covid-19 mRNA vaccine candidate
Published:
2023-02-01
(Crawled : 14:00)
- biospace.com/
GRNA
|
$0.2995
-0.03%
-0.07%
0
|
Professional, Scientific, and T...
|
-72.52%
|
O:
6.24%
H:
0.0%
C:
-5.87%
covid-19
candidate
vaccine
mrna
trial
approval
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
Published:
2022-12-08
(Crawled : 13:20)
- biospace.com/
BIXT
|
$0.117
490.75%
140K
|
Professional, Scientific, and T...
|
-71.49%
|
O:
4.78%
H:
0.0%
C:
0.0%
covid-19
approval
1847 Holdings Announces NYSE American Listing Approval
Published:
2022-04-27
(Crawled : 17:00)
- globenewswire.com
EFSH
4
|
$1.87
-19.74%
1.6%
230K
|
Professional, Scientific, and T...
|
-4.9%
|
O:
0.0%
H:
83.67%
C:
38.78%
approval
BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
Published:
2022-04-13
(Crawled : 17:00)
- biospace.com/
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-72.15%
|
O:
11.0%
H:
2.27%
C:
-17.91%
fda
immunotherapy
approval
cancer
breast cancer
Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA™ (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine
Published:
2021-09-03
(Crawled : 13:00)
- globenewswire.com
IMPL
4
|
$0.2411
-77.19%
860K
|
Professional, Scientific, and T...
|
-98.21%
|
O:
46.24%
H:
2.78%
C:
-44.84%
nasal spray
treatment
fda
migraine
fda approval
approval
Synaptogenix Responds to FDA Approval of Aducanumab
Published:
2021-06-07
(Crawled : 16:00)
- prnewswire.com
SNPX
|
$4.73
1.72%
1.69%
120K
|
Professional, Scientific, and T...
|
-31.03%
|
O:
7.76%
H:
26.67%
C:
-8.67%
fda
fda approval
approval
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.